• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Editor's Note: Relates to: 'Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society '.编者按：与《家族性高胆固醇血症在普通人群中诊断不足且治疗不充分：临床医生预防冠心病指南：欧洲动脉粥样硬化学会共识声明》相关。
Eur Heart J. 2020 Dec 14;41(47):4517. doi: 10.1093/eurheartj/ehaa166.
2
Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society.家族性高胆固醇血症在普通人群中漏诊和治疗不足：预防冠心病的临床医生指南：欧洲动脉粥样硬化学会共识声明。
Eur Heart J. 2013 Dec;34(45):3478-90a. doi: 10.1093/eurheartj/eht273. Epub 2013 Aug 15.
3
[Homozygous familial hypercholesterolaemia: Spanish adaptation of the position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society. Consensus document of the Spanish Society of Arteriosclerosis (SEA) and Familial Hypercholesterolaemia Foundation (FHF)].[纯合子家族性高胆固醇血症：欧洲动脉粥样硬化学会家族性高胆固醇血症共识小组立场文件的西班牙文改编版。西班牙动脉硬化学会（SEA）和家族性高胆固醇血症基金会（FHF）的共识文件]
Clin Investig Arterioscler. 2015 Mar-Apr;27(2):80-96. doi: 10.1016/j.arteri.2015.01.002. Epub 2015 Mar 8.
4
Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel.定义严重家族性高胆固醇血症及其对临床管理的影响：国际动脉粥样硬化学会严重家族性高胆固醇血症专家组的共识声明。
Lancet Diabetes Endocrinol. 2016 Oct;4(10):850-61. doi: 10.1016/S2213-8587(16)30041-9. Epub 2016 May 27.
5
New EAS Consensus Statement on FH: improving the care of FH patients.欧洲动脉粥样硬化学会（EAS）关于家族性高胆固醇血症（FH）的新共识声明：改善FH患者的治疗。
Atherosclerosis. 2013 Nov;231(1):69-71. doi: 10.1016/j.atherosclerosis.2013.08.035. Epub 2013 Sep 7.
6
[Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society].[纯合子家族性高胆固醇血症：临床医生提高检测和临床管理水平的新见解与指导。欧洲动脉粥样硬化学会家族性高胆固醇血症共识小组立场文件]
Turk Kardiyol Dern Ars. 2015 Mar;43 Suppl 1:1-14.
7
First insights from the EAS familial hypercholesterolaemia collaboration registry: FH is still underdiagnosed and undertreated.欧洲动脉粥样硬化学会家族性高胆固醇血症协作登记处的初步见解：家族性高胆固醇血症仍未得到充分诊断和治疗。
Atherosclerosis. 2019 Nov;290:138-139. doi: 10.1016/j.atherosclerosis.2019.09.015. Epub 2019 Sep 28.
8
Homozygous familial hypercholesterolaemia: update on management.纯合子家族性高胆固醇血症：管理进展
Paediatr Int Child Health. 2016 Nov;36(4):243-247. doi: 10.1080/20469047.2016.1246640.
9
Familial hypercholesterolaemia.家族性高胆固醇血症
Curr Opin Cardiol. 2014 Jul;29(4):381-8. doi: 10.1097/HCO.0000000000000083.
10
A comparison of European and US guidelines for familial hypercholesterolaemia.欧洲和美国家族性高胆固醇血症指南的比较
Curr Opin Lipidol. 2015 Jun;26(3):215-20. doi: 10.1097/MOL.0000000000000178.

引用本文的文献

1
In vitro assessment of the pathogenicity of the LDLR c.2160delC variant in familial hypercholesterolemia.体外评估 LDLR c.2160delC 变异在家族性高胆固醇血症中的致病性。
Lipids Health Dis. 2023 Jun 20;22(1):77. doi: 10.1186/s12944-023-01848-6.
2
[Advances in diagnosis and treatment of familial hypercholesterolemia].[家族性高胆固醇血症的诊断与治疗进展]
Nan Fang Yi Ke Da Xue Xue Bao. 2023 Jan 20;43(1):153-156. doi: 10.12122/j.issn.1673-4254.2023.01.22.
3
The promising novel therapies for familial hypercholesterolemia.家族性高胆固醇血症的有前途的新型疗法。
J Clin Lab Anal. 2022 Jul;36(7):e24552. doi: 10.1002/jcla.24552. Epub 2022 Jun 17.

Editor's Note: Relates to: 'Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease : Consensus Statement of the European Atherosclerosis Society '.

出版信息

Eur Heart J. 2020 Dec 14;41(47):4517. doi: 10.1093/eurheartj/ehaa166.

DOI:10.1093/eurheartj/ehaa166
PMID:32167556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7767633/
Abstract
摘要